GLSI vs JNJ · $144.9M cap vs P/E 17, rev $49.37B
Greenwich Lifesciences Inc (GLSI) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Greenwich Lifesciences Inc (GLSI) is a biotechnology company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
GLSI does not have a complete income-statement cache yet.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
GLSI currently screens at market cap $144.9M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the GLSI and JNJ stock pages for the full models.
Not investment advice.